Literature DB >> 19015170

Does bacteriuria interfere with albuminuria measurements of patients with diabetes?

Caroline K Kramer1, Joíza Camargo, Eliza D Ricardo, Fernando K Almeida, Luís H Canani, Jorge L Gross, Mirela J Azevedo.   

Abstract

BACKGROUND: Urinary albumin is the main parameter employed to diagnose diabetic nephropathy (DN). The exclusion of bacteriuria has been recommended at the time of DN diagnosis. This approach has been debated and information on this suggestion in patients with diabetes is scarce. The present case-control study was conducted to investigate the interference of bacteriuria in the interpretation of urinary albumin measurements in random urine samples of diabetic patients.
METHODS: Urinary albumin concentration (UAC) was measured in random urine samples twice in diabetic patients with and without bacteriuria (> or =10(5) colony-forming units/mL). Cases (n = 81) were defined as patients who had baseline UAC measurement in the presence of bacteriuria and had the second UAC measured in a sterile urine sample. Controls (n = 80) had the two UAC measured in sterile urine specimens.
RESULTS: Baseline UAC was not different between case [15.4 (1.5-2148) mg/L] and control groups [14.2 (1.5-1292) mg/L; P = 0.24], nor was the proportion of patients with normo-, micro- and macroalbuminuria. In cases, UAC measurements in the presence of bacteriuria and in sterile urine specimens were not different [15.4 (1.5-2148) versus 13.7 (1.5-2968) mg/L; P = 0.14)], nor was the proportion of normo- (51.9% versus 61.5%), micro- (40.7% versus 32.1%) and macroalbuminuria (7.4% versus 6.4%; P = 0.46). In the control group, UAC values were also not different in the two urine samples: [14.2 (1.5-1292) versus 9.7 (1.5-1049) mg/L, P = 0.22].
CONCLUSIONS: The presence of bacteriuria does not interfere significantly with urinary albumin measurements and its exclusion is not necessary to diagnose DN.

Entities:  

Mesh:

Year:  2008        PMID: 19015170     DOI: 10.1093/ndt/gfn629

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  3 in total

1.  The 2021-2022 position of Brazilian Diabetes Society on diabetic kidney disease (DKD) management: an evidence-based guideline to clinical practice. Screening and treatment of hyperglycemia, arterial hypertension, and dyslipidemia in the patient with DKD.

Authors:  João Roberto de Sá; Erika Bevilaqua Rangel; Luis Henrique Canani; Andrea Carla Bauer; Gustavo Monteiro Escott; Themis Zelmanovitz; Marcello Casaccia Bertoluci; Sandra Pinho Silveiro
Journal:  Diabetol Metab Syndr       Date:  2022-06-11       Impact factor: 5.395

Review 2.  Meta-analysis of the significance of asymptomatic bacteriuria in diabetes.

Authors:  Marjo Renko; Päivi Tapanainen; Päivi Tossavainen; Tytti Pokka; Matti Uhari
Journal:  Diabetes Care       Date:  2010-10-11       Impact factor: 19.112

3.  Diabetic nephropathy.

Authors:  Themis Zelmanovitz; Fernando Gerchman; Amely Ps Balthazar; Fúlvio Cs Thomazelli; Jorge D Matos; Luís H Canani
Journal:  Diabetol Metab Syndr       Date:  2009-09-21       Impact factor: 3.320

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.